You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Comparison of conventional transarterial chemoembolization (cTACE) with doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma
- In: Posters
- At: Dublin (Ireland) (2013)
- Type: Poster
- By: HUA, Shih-Chun (Cathay General Hospital, Taipei, China Taiwan)
- Co-author(s): Wu, Shwu-Ying (Cathay General Hospital, Taipei, China Taiwan)
Huang, Wan-Tsui (Cathay General Hospital, Taipei, China Taiwan) - Abstract:
Background
Transarterial chemoembolization (TACE) has been the main treatment for unresectable hepatocellular carcinoma (HCC). Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) is a newly developed treatment to improve drug delivery with lower systemic toxicity.
Aims
This retrospective study aimed to compare the outcomes.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026